INSULIN &OTHER GLUCOSE LOWERING DRUGS
Diabetes Mellitus
Heterogenous group of syndromes characterizes by elevated Blood Glucose level caused by relative or absolute deficiency of INSULIN.
Pancreas is an Endogenous gland, produces Insulin, Glucagon, Somatastatin…
Pancreas is also an exogenous gland produce digestive enzymes…β-cells produce
insulin, α-cells Glucagon, δ-cells produce Somatostatin…
Type-1 Diabetes Mellitus
young individual, Autoimmune destruction of β-cells, Pancreas fail to respond Glucose……..required Exogenous Insulin to avoid Catabolic state characterized by Hyperglycemia & Ketoacidosis…..
Insulin deficiency symptoms Polydipsia, Polyphagia, Polyuria, weight loss
Type-2 Diabetes Mellitus
by Genetic factor, obesity, aging, peripheral insulin resistance older patients...β-cells become resistance to insulin...infection lead to
Amputation
Gestational Diabetes Mellitus
abnormality ofglucose in first term of Pregnancy
Insulin & its analogue
MOA
insulin secretion triggered by High Glucose…Glucokiase act as Glucose sensor...
Glucose taken up into the β-cell...phosphorylated by Glucokinase…products of Glucose met.
Enter in Mitochondria…generate ATP….increase ATP block K+ channel…depolarization…influx of Ca++…..insulin exocytosis…
Sources of insulin=recombinant DNA from Escherichia or yeast
Short/Rapid Acting Insulin
Regular insulin, Insulin Lispro, Insulin Aspart pregnancy category B…….., Insulin Glulisine pregnancy category C…..insulin lispro 30-90min
peak level…Insulin Aspart & Glulisine ara Rapid acting
Intermediate-Acting Insulin
NPH (Neutral Protamine Hagedorn) suspension of crystalline zinc insulin at neutral pH +Ve charged……
Long –Acting Insulin
Insulin Glargine isoelectric point lower than human insulin... no peak effect
Insulin Detemir
has fatty acid side chain...bind to Albumin..
Amylin Analogue
Pramlintide synthetic amylin analogue...an adjunct to mealtime insulin…delay gastric
emptying…decrease postprandial Glucagon secretion...imporve satiety….used in
diabetic gastroparesis (delay stomch emptying)…..
not mixed with any insulin prep in
syringe…
S.E; Anorexia, vomiting,, nausea..
Insulin Sectretagogue;
Sulfonylurea
MOA same to insulin…useful in Diabetes type-2…classified secretagogue bcz produce
Insulin from β-cells….orally...12-24hr duration...
S.E;weight gain, hypoglycemia...safe in
preganancy...caution in hepatic & renal impair
Glinides
Rapaglinide & Nateglinide
MOA like insulin…have rapid onset & short duration of action called Postprandial Glucose Regulator bcz early release of insulin after
meal…
S.E
Hypoglycemia, weight gain ...used with caution in hepatic impair…use with Gemfibrozil is contraindicated
Insulin sensitizer
Biguanides
Metformin only currently used…does not promote insulin secretion
MOA : reduction of hepatic glucose output…inhibit Gluuconeognesis…slow intestinal
abs. of sugars...improve peripheral glucose uptake & utilization…
reduce hyperlipidemia... decrease insulin resistance…increase HDL…
used in pregnancy
T.E
used in Diabetic Ketooacidosis, DOC in type-2 Diabetes, Polysystic ovarydisease
S.E
GIT disturbance, contraindicated in pt.with lver/renal impair, M.I, CHF, Lactic
acidosis….interfere with vit B12 Abs.
Glitazone/Thiazolidinediones TZDs
Traglitazine withdraw due to hepatotxicity…
MOA= bind to PPARγ….Peroxisome-Proliferator-activated receptor-γ …regulate
Adipocyte production….secretion of fatty acid…glucose met…insulin sensitivity in liver,
adipose tissue, skeletal muscle…Hyperglycemia,Hyperinsulinemia,Elevated HbA1c,
hypertricglycemia….HDL level incrase
S.E
weight gain, Osteopenia, increased Fracture risk, anemia...cause Ovulation in postmenopausal women so take Contraceptive while taking TZDs....not used in lactation
α-Glucosidase Inhibitors
Acarbose & Miglitol=used in Diabetes type-2
MOA= used in beginning of meal...inhibit α-Glucosidase….enzyme responsible
hydrolysis of Oligosacharide to glucose & other sugar…..delay digestion of C.H.O…
decrease postprandial glucose level…also inhibit α-amylase...inhibit breakdown of Starch into Oligosacchaaride
S.E= diarrhea, cramps, Flatulance…contra in ulcer & intestinal obstruction
Dipeptidyl Peptidase-IV inhibitor
Sitagliptin & Saxagliptin
inhibit DPP-IV...responsible for inactivation of Incretin hormone…result increase Incretin...increase Insulin.
S.E= Pancreatitis, Headache, Nasopharyngitis,
Incretin mimetics
Exenatide & Liraglutide=analogue of GLP-1(Glucagon like peptide)…increase
Glucose dependent Insulin secretion …Slow Gastric emptying…decrease postprandial Glugagon
Secretion, promote β-cell Proliferation…Liraglutide O.D used...
Exenatide twice inj...Weight gain reduced.
S.E=Constipation, Pancreatitis, Abdominal pain
Comments
Post a Comment